DE60234111D1 - Abgabe von krankheitsbekämpfung in aquakultur und landwirtschaft unter verwendung von nährstoffuttermitteln, die von viren produzierte biologisch aktive proteine enthalten - Google Patents

Abgabe von krankheitsbekämpfung in aquakultur und landwirtschaft unter verwendung von nährstoffuttermitteln, die von viren produzierte biologisch aktive proteine enthalten

Info

Publication number
DE60234111D1
DE60234111D1 DE60234111T DE60234111T DE60234111D1 DE 60234111 D1 DE60234111 D1 DE 60234111D1 DE 60234111 T DE60234111 T DE 60234111T DE 60234111 T DE60234111 T DE 60234111T DE 60234111 D1 DE60234111 D1 DE 60234111D1
Authority
DE
Germany
Prior art keywords
aquaculture
agriculture
disorder
distribution
biological active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60234111T
Other languages
English (en)
Inventor
David J Kyle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Bionutrtion Corp
Original Assignee
Advanced Bionutrtion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Bionutrtion Corp filed Critical Advanced Bionutrtion Corp
Application granted granted Critical
Publication of DE60234111D1 publication Critical patent/DE60234111D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/13—Immunoglobulins specific features characterized by their source of isolation or production isolated from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish
    • Y02A40/818—Alternative feeds for fish, e.g. in aquacultures

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Husbandry (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Physiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Insects & Arthropods (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Feed For Specific Animals (AREA)
DE60234111T 2001-08-27 2002-08-27 Abgabe von krankheitsbekämpfung in aquakultur und landwirtschaft unter verwendung von nährstoffuttermitteln, die von viren produzierte biologisch aktive proteine enthalten Expired - Lifetime DE60234111D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31463701P 2001-08-27 2001-08-27
PCT/US2002/027198 WO2003017780A1 (en) 2001-08-27 2002-08-27 Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses

Publications (1)

Publication Number Publication Date
DE60234111D1 true DE60234111D1 (de) 2009-12-03

Family

ID=23220785

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60234111T Expired - Lifetime DE60234111D1 (de) 2001-08-27 2002-08-27 Abgabe von krankheitsbekämpfung in aquakultur und landwirtschaft unter verwendung von nährstoffuttermitteln, die von viren produzierte biologisch aktive proteine enthalten

Country Status (8)

Country Link
US (1) US20040081638A1 (de)
EP (1) EP1429623B1 (de)
AT (1) ATE446017T1 (de)
CA (1) CA2459141A1 (de)
DE (1) DE60234111D1 (de)
MX (1) MXPA04001660A (de)
NO (1) NO20041239L (de)
WO (1) WO2003017780A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7550647B2 (en) 2001-09-14 2009-06-23 Advanced Bionutrition Transfected shrimp as production systems for therapeutic proteins
WO2004003143A2 (en) * 2002-06-26 2004-01-08 Advanced Bionutrition Corporation Viruses and virus-like particles for multiple antigen and target display
EP1545600A4 (de) * 2002-09-16 2006-07-12 Advanced Bionutrition Corp Protein- und peptid-expression für passive immunität
AU2003294244A1 (en) * 2002-11-07 2004-06-03 Advanced Bionutrition Corp. Nutraceuticals and method of feeding aquatic animals
TW201139672A (en) 2002-12-13 2011-11-16 Novartis Ag Immunization of fish with plant-expressed recombinant proteins
US7973148B2 (en) * 2004-04-15 2011-07-05 Advanced Bionutrition Corporation Crustacean expression vector
US20100126424A1 (en) * 2004-06-17 2010-05-27 Benjamin Moll Managed Co-cultures of Organisms Having Prophylactic and Health-Promoting Effects
US7241598B2 (en) * 2004-06-29 2007-07-10 The Chinese University Of Hong Kong Frame-shifting PCR for germline immunoglobulin genes retrieval and antibody engineering
CN101023095B (zh) * 2004-07-09 2013-07-03 绿色生命实验室有限公司 基因工程蛋白质p40及其应用
CN101291591B (zh) * 2005-10-19 2013-06-19 希尔氏宠物营养品公司 制备食物组合物的方法
WO2007075988A2 (en) * 2005-12-21 2007-07-05 Advanced Bionutrition Corporation Non-invasive detection of fish viruses by real-time pcr
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
EP1973406B1 (de) 2005-12-28 2014-03-12 Advanced Bionutrition Corporation Abgabekonstituens für probiotische bakterien umfassend eine trockene matrix aus polysacchariden, sacchariden und polyolen in glasform
EP1981338A2 (de) * 2006-01-13 2008-10-22 Advanced Bionutrition Corporation Produktionssystem mit kontinuierlicher sprühnebelaufnahme
AU2007235419A1 (en) * 2006-04-03 2007-10-18 Advanced Bionutrition Corporation Feed formulations containing docosahexaenoic acid
CA2673120C (en) 2006-12-18 2012-08-07 Advanced Bionutrition Corporation A dry food product containing live probiotic
GB2477712A (en) 2006-12-20 2011-08-17 Advanced Bionutrition Corp Antigenicity of infectious pancreatic necrosis virus VP2 sub-viral particles expressed in yeast
US20080194003A1 (en) * 2007-02-13 2008-08-14 Jere Northrop System for producing food and feed
US9259662B2 (en) 2008-02-22 2016-02-16 James Weifu Lee Photovoltaic panel-interfaced solar-greenhouse distillation systems
US8673119B2 (en) * 2008-02-22 2014-03-18 James Weifu Lee Photovoltaic panel-interfaced solar-greenhouse distillation systems
US10093552B2 (en) 2008-02-22 2018-10-09 James Weifu Lee Photovoltaic panel-interfaced solar-greenhouse distillation systems
US7998502B2 (en) * 2008-03-24 2011-08-16 Advanced Bionutrition Corp. Encapsulated vaccines for the oral vaccination and boostering of fish and other animals
US8778384B2 (en) 2008-03-24 2014-07-15 Advanced Bionutrition Corporation Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
WO2010040545A1 (en) * 2008-10-06 2010-04-15 Novoplant Gmbh Proteolytically stable antibody formats
WO2010111565A2 (en) 2009-03-27 2010-09-30 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
PL2435554T3 (pl) 2009-05-26 2018-01-31 Advanced Bionutrition Corp Stabilna kompozycja suchego proszku zawierająca biologicznie aktywne mikroorganizmy i/lub materiały bioaktywne i sposoby jej wykonania
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
SG182317A1 (en) 2010-01-28 2012-08-30 Advanced Bionutrition Corp Dry glassy composition comprising a bioactive material
PL2603100T3 (pl) 2010-08-13 2019-06-28 Advanced Bionutrition Corp. Kompozycja stabilizująca przechowywanie na sucho materiałów biologicznych
US8822427B2 (en) 2010-10-27 2014-09-02 Harrisvaccines Methods and compositions to protect aquatic invertebrates from disease
EP2632486A1 (de) 2010-10-27 2013-09-04 Harrisvaccines Inc Verfahren zur schnellen herstellung von impfstoffen für tiere
US10004797B2 (en) 2010-10-27 2018-06-26 Harrisvaccines, Inc. Method of rapidly producing improved vaccines for animals
JP5704646B2 (ja) * 2011-06-08 2015-04-22 日本電信電話株式会社 半導体光変調器
RU2570315C1 (ru) 2011-10-14 2015-12-10 Хилл'С Пет Ньютришн, Инк. Способ приготовления кормовой композиции для домашних животных
IL230970A0 (en) 2014-02-13 2014-09-30 Univ Ramot Tilapia virus vaccines
BR112017012852A2 (pt) 2014-12-15 2018-01-09 The Trustees Of Columbia University In The City Of New York novo vírus de tilápia e usos do mesmo
CA2994112C (en) 2015-07-29 2023-08-08 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
CN109811003A (zh) * 2019-01-27 2019-05-28 天津师范大学 一种通过转化凡纳滨对虾抗菌肽pen3基因提高浮萍及其液体培养基抗菌能力的方法
WO2022104279A1 (en) * 2020-11-16 2022-05-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Vibrio toxin binding proteins in shrimp and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3889007A (en) * 1973-01-26 1975-06-10 Ocean Food Inc Aquatic animal food composition
NL7704040A (nl) * 1976-04-28 1977-11-01 Merck & Co Inc Werkwijze voor het bereiden van nieuwe anti- biotica.
US5202422A (en) * 1989-10-27 1993-04-13 The Scripps Research Institute Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use
GB9403819D0 (en) * 1994-02-28 1994-04-20 Univ Leeds Control of parasites
US5681746A (en) * 1994-12-30 1997-10-28 Chiron Viagene, Inc. Retroviral delivery of full length factor VIII
US5618574A (en) * 1995-05-12 1997-04-08 Clearwater Fish & Pond Supply, Inc. Fish food
US6462027B2 (en) * 1998-07-06 2002-10-08 University Of Georgia Research Foundation, Inc. Delivery of nucleic acid into aquatic animals

Also Published As

Publication number Publication date
EP1429623A1 (de) 2004-06-23
NO20041239D0 (no) 2004-03-24
NO20041239L (no) 2004-05-24
WO2003017780A1 (en) 2003-03-06
MXPA04001660A (es) 2004-11-22
ATE446017T1 (de) 2009-11-15
EP1429623B1 (de) 2009-10-21
CA2459141A1 (en) 2003-03-06
EP1429623A4 (de) 2005-09-14
US20040081638A1 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
DE60234111D1 (de) Abgabe von krankheitsbekämpfung in aquakultur und landwirtschaft unter verwendung von nährstoffuttermitteln, die von viren produzierte biologisch aktive proteine enthalten
ATE400189T1 (de) Abgabe von mitteln zur krankheitskontrolle in aquakultur unter verwendung von bioaktive proteine enthaltender hefe
ATE127694T1 (de) Lebende impfstoffe.
ATE443437T1 (de) Modifiziertes bacillus thuringiensis gen zur kontrolle von lepidoptera in pflanzen
Murhammer Baculovirus and insect cell expression protocols
Husseneder et al. Genetically engineered yeast expressing a lytic peptide from bee venom (melittin) kills symbiotic protozoa in the gut of formosan subterranean termites
CN104988170B (zh) 一种融合抗菌肽及其制备方法和应用
Zeng et al. A high soldier proportion encouraged the greater antifungal immunity in a subterranean termite
Bogut et al. The influence of polyzymes added to the food on the growth of carp fingerlings (Cyprinus carpio L.)
MX9605278A (es) Procedimiento para la inactivacion de virus en proteinas.
DE60142356D1 (de) 18480 humane proteinkinasemoleküle und ihre verwendungen
WO2020049118A1 (en) Animal luring device
Qin et al. Gene Editing of the Follicle-Stimulating Hormone Gene to Sterilize Channel Catfish, Ictalurus punctatus, Using a Modified Transcription Activator-like Effector Nuclease Technology with Electroporation
Ahmad et al. Transgenesis in animals: Principles and applications–A review
Sadiq et al. Recent Trends and Applications in Biological Sciences, Zoology, Botany and Agricultural Sciences
ATE459643T1 (de) Ee3-proteinfamilie und zugrundeliegende dna- sequenzen
Engelhard Pharming–an Introduction
Bhaskar Future of Mariculture with the Advent of Modern Biotechnology Tools
Regnault-Roger Biotechnology: Timeless, Essential, and Omnipresent
Ananthakrishnan Biotechnology in insect control
Magnus et al. Transgenic milk
Nicklin Medical Issues: The Future Impact of Biotechnology on Human Factors
Meade Dairy gene
Young et al. “Old” Biotechnology to “New” Biotechnology: Continuum or Disjunction?
Ramakrishnan Is organic chemistry undergoing a metamorphosis?

Legal Events

Date Code Title Description
8364 No opposition during term of opposition